Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen

Autor: Berislav V. Zlokovic, Michael G. Harrington, Abhay P. Sagare, Noah B. Gross, Melanie D. Sweeney, Alfred N. Fonteh, Xianghong Arakaki, Axel Montagne, Janice M. Pogoda, Robert Cowan

Publikováno v: Headache
Cowan, R P, Gross, N B, Sweeney, M D, Sagare, A P, Montagne, A, Arakaki, X, Fonteh, A N, Zlokovic, B V, Pogoda, J M & Harrington, M G 2021, ' Evidence that blood–CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen ', Headache, vol. 61, no. 3, pp. 536-545 . https://doi.org/10.1111/head.14088

Objective: Our objective is to explore whether blood–cerebrospinal fluid (CSF) barrier biomarkers differ in episodic migraine (EM) or chronic migraine (CM) from controls. Background: Reports of blood–brain barrier and blood–cerebrospinal fluid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39d78cffd21c237acfd17005c14f283
https://pubmed.ncbi.nlm.nih.gov/33724462

Activation of α7 nicotinic acetylcholine receptors protects potentiated synapses from depotentiation during theta pattern stimulation in the hippocampal CA1 region of rats

Autor: Bryan A. Galvez, Katumi Sumikawa, Noah B. Gross

Publikováno v: Neuropharmacology. 105:378-387

Long-term potentiation (LTP) shows memory-like consolidation and thus becomes increasingly resistant to disruption by low-frequency stimulation (LFS). However, it is known that nicotine application during LFS uniquely depotentiates consolidated LTP.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::716a1396c907f10bb8dd38bab345ca39
https://doi.org/10.1016/j.neuropharm.2016.02.008

Severe Headache or Migraine History Is Inversely Correlated With Dietary Sodium Intake: NHANES 1999-2004: A Response

Autor: Janice M. Pogoda, Noah B. Gross, Xianghong Arakaki, Alfred N. Fonteh, Robert P. Cowan, Michael G. Harrington

Publikováno v: Headache: The Journal of Head and Face Pain. 56:1216-1218

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2ccc532ba846a9c09ff1810424d1511e
https://doi.org/10.1111/head.12868

Cortical ionotropic glutamate receptor antagonism protects against methamphetamine-induced striatal neurotoxicity

Autor: Patrick C. Duncker, Noah B. Gross, John F. Marshall

Binge administration of the psychostimulant drug, methamphetamine (mAMPH), produces long-lasting structural and functional abnormalities in the striatum. mAMPH binges produce non-exocytotic release of dopamine (DA), and mAMPH-induced activation of ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f57556ae439770c82e0fd57a37d3cf5
https://europepmc.org/articles/PMC3237791/

Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression

Autor: Noah B. Gross, John F. Marshall

Publikováno v: Neuroscience. 161(4)

Methamphetamine (mAMPH) is a psychostimulant drug that increases extracellular levels of monoamines throughout the brain. It has previously been observed that a single injection of mAMPH increases immediate early gene (IEG) expression in both the str

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d5e43aba459df8469ac3193adc00002
https://pubmed.ncbi.nlm.nih.gov/19374938